Lincoln Capital Corp’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-37,280
| Closed | -$127K | – | 57 |
|
|
2018
Q3 | $127K | Sell |
37,280
-28,520
| -43% | -$97.2K | 0.11% | 46 |
|
|
2018
Q2 | $247K | Sell |
65,800
-2,110
| -3% | -$7.92K | 0.23% | 41 |
|
|
2018
Q1 | $278K | Buy |
67,910
+1,000
| +1% | +$4.09K | 0.26% | 44 |
|
|
2017
Q4 | $311K | Buy |
66,910
+30,410
| +83% | +$141K | 0.27% | 41 |
|
|
2017
Q3 | $259K | Hold |
36,500
| – | – | 0.23% | 42 |
|
|
2017
Q2 | $264K | Buy |
36,500
+6,200
| +20% | +$44.8K | 0.23% | 44 |
|
|
2017
Q1 | $187K | Buy |
30,300
+3,500
| +13% | +$21.6K | 0.17% | 50 |
|
|
2016
Q4 | $158K | Buy |
+26,800
| New | +$158K | 0.15% | 49 |
|